JILIN CHANGLONG(08049.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
JILIN CHANGLONG
08049.HK
Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It also engages in the manufacture and distribution of beverages and prepackaged food, as well as health products. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
1.239 T
08049.HKMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking35/53
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE11.99%B
    • Profit Margin22.05%A
    • Gross Margin84.01%A
  • Growth ScoreC
    • Revenue YoY3.34%C
    • Net Profit YoY8.99%C
    • Total Assets YoY10.31%B
    • Net Assets YoY8.30%B
  • Cash ScoreC
    • Cash Flow Margin157.50%B
    • OCF YoY3.34%C
  • Operating ScoreD
    • Turnover0.35D
  • Debt ScoreB
    • Gearing Ratio36.79%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Morning Trend | JILIN CHANGLONG's main force tests again, is a medium-term swing opportunity emerging?

    Technical Forecast·
    HK
    08049
    -0.42%
    Technical Forecast·
    HK
    08049
    -0.42%

    JILIN CHANGLONG subscribed to RMB 50 million of China Industrial and Commercial Bank wealth management products

    Zhitong·
    SH
    601398
    -1.38%
    HK
    01398
    -1.44%
    HK
    08049
    -0.42%
    Zhitong·
    SH
    601398
    -1.38%
    HK
    01398
    -1.44%
    HK
    08049
    -0.42%

    JILIN CHANGLONG subscribed to ICBC wealth management products worth 50 million yuan

    Zhitong·
    SH
    601398
    -1.38%
    HK
    01398
    -1.44%
    HK
    08049
    -0.42%
    Zhitong·
    SH
    601398
    -1.38%
    HK
    01398
    -1.44%
    HK
    08049
    -0.42%

    JILIN CHANGLONG released its interim results, with a profit attributable to shareholders of 103 million yuan, a year-on-year decrease of 1.2%

    Zhitong·
    HK
    08049
    -0.42%
    Zhitong·
    HK
    08049
    -0.42%

    Zhitong Hong Kong Stock Investment Journal | July 18

    Zhitong·
    HK
    03616
    0.00%
    HK
    08049
    -0.42%
    HK
    03348
    0.00%
    Zhitong·
    HK
    03616
    0.00%
    HK
    08049
    -0.42%
    HK
    03348
    0.00%
    © 2026 Longbridge｜Disclaimer